Sughrue Michael E, Yang Isaac, Rutkowski Martin J, Aranda Derick, Parsa Andrew T
Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave., San Francisco, CA 94143, USA.
Br J Neurosurg. 2010 Dec;24(6):666-71. doi: 10.3109/02688697.2010.520761.
Most data regarding facial nerve function in patients undergoing microsurgical resection of vestibular schwannomas predominantly include series performed at a single institution. In an effort to minimise individual surgeon or institutional bias, we performed an analysis of the published literature on facial nerve outcomes following microsurgical resection of vestibular schwannomas. The objective of this study was to provide a comprehensive assessment of reported outcomes for facial nerve preservation after VS surgery.
We identified a total of 296 studies involving over 25,000 patients that included outcome data for facial nerve function of vestibular schwannoma patients treated surgically. Data regarding surgical approach, tumour size, patient age, and use of intra-operative monitoring were extracted and correlated with facial nerve function after surgery. Patients with preoperative facial nerve dysfunction (House-Brackmann score 3 or higher) were excluded and 'facial nerve preservation' was defined as grade I or II House-Brackmann function at last follow-up visit.
A total of 79 articles reporting on 11,873 patients met our inclusion criteria contributing to our analysis. Patients treated with the middle cranial fossa approach had a trend towards higher overall facial nerve preservation rate (85%), compared to the translabyrinthine approach (81%, p = 0.07) , and did statistically better than the retrosigmoid approach (78%, p < 0.0001). Patients with an average tumour size <20 mm had significantly improved facial nerve preservation rates, compared to larger tumours (90% vs. 67%, p < 0.0001). Patients under 65 years of age had a lower facial nerve preservation rate (71% vs. 84%, p < 0.001). Finally, the use of intra-operative monitoring improved the facial nerve preservation rate (76% vs. 71%, p < 0.001).
Factors that appear to be associated with facial nerve preservation after microsurgical resection of a vestibular schwannoma include tumour size <20 mm, use of the middle fossa approach and use of neuromonitoring during surgery. These data provide a summary assessment of the published literature regarding facial nerve preservation after microsurgical resection of vestibular schwannoma.
大多数关于接受前庭神经鞘瘤显微手术切除患者面神经功能的数据主要来自单一机构开展的系列研究。为尽量减少个体外科医生或机构的偏倚,我们对已发表的关于前庭神经鞘瘤显微手术切除后面神经转归的文献进行了分析。本研究的目的是全面评估前庭神经鞘瘤(VS)手术后面神经保留的报告转归。
我们共识别出296项涉及超过25000例患者的研究,这些研究包含接受手术治疗的前庭神经鞘瘤患者面神经功能的转归数据。提取有关手术入路、肿瘤大小、患者年龄及术中监测使用情况的数据,并将其与术后面神经功能相关联。排除术前存在面神经功能障碍(House-Brackmann评分3级或更高)的患者,“面神经保留”定义为最后一次随访时House-Brackmann功能为Ⅰ级或Ⅱ级。
共有79篇报告11873例患者的文章符合我们的纳入标准,为我们的分析提供了数据。与经迷路入路(81%,p = 0.07)相比,采用中颅窝入路治疗的患者总体面神经保留率有更高的趋势(85%),且在统计学上优于乙状窦后入路(78%,p < 0.0001)。平均肿瘤大小<20 mm的患者与较大肿瘤患者相比,面神经保留率显著提高(90%对67%,p < 0.0001)。65岁以下患者的面神经保留率较低(71%对84%,p < 0.001)。最后,术中监测的使用提高了面神经保留率(76%对71%,p < 0.001)。
前庭神经鞘瘤显微手术切除后与面神经保留相关的因素包括肿瘤大小<20 mm、采用中颅窝入路以及术中使用神经监测。这些数据对已发表的关于前庭神经鞘瘤显微手术切除后面神经保留的文献进行了总结评估。